Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$7,075
-$729 QoQ
Shares Held
56
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,198
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centerpoint Advisors, LLC holds $2,533,470 across 10 Drug Manufacturers - General names. GILD ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,965 | $1,006,991 | |
| 2 | LLY |
ELI LILLY & Co
|
817 | $979,934 | |
| 3 | ABBV |
AbbVie Inc.
|
1,182 | $297,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,035 | $132,997 | |
| 5 | PFE |
Pfizer Inc
|
3,152 | $75,900 | |
| 6 | BIIB |
Biogen Inc.
|
83 | $17,932 | |
| 7 | AMGN |
Amgen Inc
|
28 | $10,139 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
56 | $7,075 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,075 | 56 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $7,804 | 56 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,873 | 56 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,216 | 56 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||